Hydrogenology
Hydrogenology editorial study record

Acute pre-exercise hydrogen rich water intake does not improve running performance at maximal aerobic speed in trained track and field runners

Valenta M et al. · PLoS One. 2022;17(12):e0279307.

HumanH₂-rich waterPublished 2022
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Human

Reported design

Randomized double-blind placebo-controlled crossover trial

Research topic

Exercise and recovery

Administration classification

H₂-rich water

Study result signal

Not reported in this record.

Outcome type

Not reported in this record.

Reported in the source

Methods at a glance

Population or model

Trained male track-and-field runners at national level

Sample

24 participants

Duration

Two experimental sessions with a 1-week washout; acute pre-exercise exposure

Intervention

1,260 mL hydrogen-rich water in four doses before running: 420 mL at 120 and 60 minutes, then 210 mL at 30 and 10 minutes

Hydrogen form

H₂ dissolved in water — H₂ only, not Brown’s gas.

H₂ specification

0.9 ppm dissolved H₂; total reported dose 567 µmol H₂.

H₂ flow

Not applicable — oral water, not gas inhalation.

O₂ delivered with H₂

No O₂ was co-delivered as part of the intervention.

Comparator

Visually identical placebo water with 0.0 ppm dissolved H₂

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Running time and distance to exhaustion at maximal aerobic speed, heart rate, ventilation, oxygen uptake and blood lactate

Reported result

No statistically significant differences were reported for time to exhaustion (217 ± 49 vs 227 ± 53 s; p=0.20), post-exercise lactate, maximal heart rate, oxygen uptake or the other measured cardiorespiratory variables.

Results-extraction completeness

Methods, full outcome table and conclusions checked in the open-access full text; independent appraisal remains incomplete.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

Acute, male-only, specialized maximal-aerobic-speed protocol. A null result in this experiment does not establish absence of effects in other populations, doses or exercise protocols.

Applies directly to

Trained male middle-distance runners performing an exhaustive run at their individually determined maximal aerobic speed.

Preliminary appraisal framework

Cochrane RoB 2 crossover variant · time-to-exhaustion result

Preliminary risk-of-bias status

Some concerns — preliminary; independent reviewer pending

Appraisal rationale

The randomized double-blind crossover design and objective outcomes are strengths, but allocation by paper-strip draw, concealment, period effects and absence of a linked prospective protocol require review.

Appraisal domains

Some concerns — block allocation by paper-strip draw is described; concealment may be vulnerable. · Low to some concerns — matched packaging and double blinding are described. · Low concern in the displayed report — 24 participants are analyzed. · Low concern — time, gas-exchange and laboratory measures are objective. · Some concerns — no linked prospective protocol or analysis plan was identified.

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 36538554 · DOI: 10.1371/journal.pone.0279307

Publisher access

Open-access publisher and PMC full texts are available.

Extraction basis

Open-access full text through Europe PMC/PMC and PubMed bibliographic record.

Record revision

2026-08-10